Revenue
0 USD
2024 Q4 · USD
295 filing records in this dataset, filed from 2000-06-28 to 2024-04-26. Reported financial figures are available; chart coverage varies by period.
4900000 USD
11857393 shares
349.37% · 9.22 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
13 thousand USD
2023-01-01 – 2023-12-31
-48.1 million USD
2023-01-01 – 2023-12-31
-29.5 million USD
2023-01-01 – 2023-12-31
54 thousand USD
2018-11-01 – 2019-10-31
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2024-04-26.
Financial data available through: 2023-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 692,000
–
Current period
USD 13,000
–
13000 − 692000 = -679000 USD
692000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source13000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 38.01 million
–
Current period
−USD 48.1 million
–
-48100000 − -38013000 = -10087000 USD
-38013000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source-48100000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 34.51 million
–
Current period
−USD 29.5 million
–
-29500000 − -34510000 = 5010000 USD
-34510000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source-29500000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2016 2015-11-01 – 2016-10-31 | 3994856 | 80487094 Derived | -76492238 | -2936008 Derived | -73556230 | -12366231 Derived | Source
|
| 2017 2016-11-01 – 2017-10-31 | 12031000 | 110477000 Derived | -98446000 | -5011000 Derived | -93435000 | -80291000 Derived | Source
|
| 2018 2017-11-01 – 2018-10-31 | 6063000 | 76442000 Derived | -70379000 | -3864000 Derived | -66515000 | -63554000 Derived | Source
|
| 2019 2018-11-01 – 2019-10-31 | 20884000 | 38856000 Derived | -17972000 | -1360000 Derived | -16612000 | -36182000 Derived | Source
|
| 2020 2019-11-01 – 2020-10-31 | 253000 | 26702000 Derived | -26449000 | 20000 Derived | -26469000 | Unavailable | Source
|
| 2021 2020-11-01 – 2021-10-31 | 3240000 | 22026000 Derived | -18786000 | -924000 Derived | -17862000 | Unavailable | Source
|
| 2022 2021-11-01 – 2022-10-31 | 250000 | 19560000 Derived | -19310000 | -4951000 Derived | -14359000 | Unavailable | Source
|
| 2023 2022-01-01 – 2022-12-31 | 692000 | 38195000 Derived | -37503000 | 510000 Derived | -38013000 | Unavailable | Source
|
| 2024 2023-01-01 – 2023-12-31 | 13000 | 36279000 Derived | -36266000 | 11834000 Derived | -48100000 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2014 | Revenue | 1000000 |
|
| 2016 | Revenue | 3994856 |
|
| 2017 | Revenue | 12031000 |
|
| 2018 | Revenue | 6063000 |
|
| 2019 | Revenue | 20884000 |
|
| 2020 | Revenue | 253000 |
|
| 2021 | Revenue | 3240000 |
|
| 2022 | Revenue | 250000 |
|
| 2023 | Revenue | 692000 |
|
| 2024 | Revenue | 13000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2014 | Year over year | No prior comparable period |
|
| 2016 | Year over year | No prior comparable period |
|
| 2017 | Year over year | 201.2% |
|
| 2018 | Year over year | -49.6% |
|
| 2019 | Year over year | 244.4% |
|
| 2020 | Year over year | -98.8% |
|
| 2021 | Year over year | 1,180.6% |
|
| 2022 | Year over year | -92.3% |
|
| 2023 | Year over year | No prior comparable period |
|
| 2024 | Year over year | -98.1% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2014 | Operating margin | -1,953.9% |
|
| 2016 | Operating margin | -1,914.8% |
|
| 2017 | Operating margin | -818.3% |
|
| 2018 | Operating margin | -1,160.8% |
|
| 2019 | Operating margin | -86.1% |
|
| 2020 | Operating margin | -10,454.2% |
|
| 2021 | Operating margin | -579.8% |
|
| 2022 | Operating margin | -7,724% |
|
| 2023 | Operating margin | -5,419.5% |
|
| 2024 | Operating margin | -278,969.2% |
|
| 2014 | Net margin | -1,652.5% |
|
| 2016 | Net margin | -1,841.3% |
|
| 2017 | Net margin | -776.6% |
|
| 2018 | Net margin | -1,097.1% |
|
| 2019 | Net margin | -79.5% |
|
| 2020 | Net margin | -10,462.1% |
|
| 2021 | Net margin | -551.3% |
|
| 2022 | Net margin | -5,743.6% |
|
| 2023 | Net margin | -5,493.2% |
|
| 2024 | Net margin | -370,000% |
|
| 2014 | Free cash flow margin | Not reported |
|
| 2016 | Free cash flow margin | -309.6% |
|
| 2017 | Free cash flow margin | -667.4% |
|
| 2018 | Free cash flow margin | -1,048.2% |
|
| 2019 | Free cash flow margin | -173.3% |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2014 | Operating cash flow | Not reported | No source recorded |
| 2016 | Operating cash flow | -9143789 |
|
| 2017 | Operating cash flow | -76842000 |
|
| 2018 | Operating cash flow | -62129000 |
|
| 2019 | Operating cash flow | -36128000 |
|
| 2020 | Operating cash flow | -21940000 |
|
| 2021 | Operating cash flow | -15439000 |
|
| 2022 | Operating cash flow | -15284000 |
|
| 2023 | Operating cash flow | -34510000 |
|
| 2024 | Operating cash flow | -29500000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2014 | Free cash flow | Unavailable | No source recorded |
| 2016 | Free cash flow | -12366231 |
|
| 2017 | Free cash flow | -80291000 |
|
| 2018 | Free cash flow | -63554000 |
|
| 2019 | Free cash flow | -36182000 |
|
| 2020 | Free cash flow | Unavailable |
|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2014 | Liabilities / assets | 11.8% |
|
| 2016 | Liabilities / assets | 29.4% |
|
| 2017 | Liabilities / assets | 42.1% |
|
| 2018 | Liabilities / assets | 61.4% |
|
| 2019 | Liabilities / assets | 12.7% |
|
| 2020 | Liabilities / assets | 21.7% |
|
| 2021 | Liabilities / assets | 16.9% |
|
| 2022 | Liabilities / assets | 8.9% |
|
| 2022-12-31 | Liabilities / assets | Not reported |
|
| 2023-12-31 | Liabilities / assets | Not reported |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2014 | Current assets / current liabilities | 7.55× |
|
| 2016 | Current assets / current liabilities | 5.77× |
|
| 2017 | Current assets / current liabilities | 3.89× |
|
| 2018 | Current assets / current liabilities | 2.21× |
|
| 2019 | Current assets / current liabilities | 8× |
|
| 2020 | Current assets / current liabilities | 8.46× |
|
| 2021 | Current assets / current liabilities | 5.49× |
|
| 2022 | Current assets / current liabilities | 11.18× |
|
| 2023 | Current assets / current liabilities | 0.51× |
|
| 2024 | Current assets / current liabilities | 0.3× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2015 2014-11-01 – 2015-10-31 | −USD 47.03 million Exact valueExact value: -47031118 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 24.16 million Exact valueExact value: -24164335 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 972,859 Exact valueExact value: 972859 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 25.14 million Calculation and evidence-24164335 − 972859 USD Exact free cash flow: -25137194 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2016 2015-11-01 – 2016-10-31 | −USD 73.56 million Exact valueExact value: -73556230 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9.14 million Exact valueExact value: -9143789 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3.22 million Exact valueExact value: 3222442 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12.37 million Calculation and evidence-9143789 − 3222442 USD Exact free cash flow: -12366231 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2017 2016-11-01 – 2017-10-31 | −USD 93.44 million Exact valueExact value: -93435000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 76.84 million Exact valueExact value: -76842000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 3.45 million Exact valueExact value: 3449000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 80.29 million Calculation and evidence-76842000 − 3449000 USD Exact free cash flow: -80291000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2018 2017-11-01 – 2018-10-31 | −USD 66.52 million Exact valueExact value: -66515000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 62.13 million Exact valueExact value: -62129000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.43 million Exact valueExact value: 1425000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 63.55 million Calculation and evidence-62129000 − 1425000 USD Exact free cash flow: -63554000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2019 2018-11-01 – 2019-10-31 | −USD 16.61 million Exact valueExact value: -16612000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 36.13 million Exact valueExact value: -36128000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 54,000 Exact valueExact value: 54000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 36.18 million Calculation and evidence-36128000 − 54000 USD Exact free cash flow: -36182000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2019-11-01 – 2020-10-31 | −USD 26.47 million Exact valueExact value: -26469000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 21.94 million Exact valueExact value: -21940000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2020-11-01 – 2021-10-31 | −USD 17.86 million Exact valueExact value: -17862000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 15.44 million Exact valueExact value: -15439000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2021-11-01 – 2022-10-31 | −USD 14.36 million Exact valueExact value: -14359000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 15.28 million Exact valueExact value: -15284000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2022-01-01 – 2022-12-31 | −USD 38.01 million Exact valueExact value: -38013000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 34.51 million Exact valueExact value: -34510000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2023-01-01 – 2023-12-31 | −USD 48.1 million Exact valueExact value: -48100000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 29.5 million Exact valueExact value: -29500000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
295 filings · 3,481 latest values · 3,481 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001100397, 1100397, ADXS, adxs, edgar:1100397
Also known as ADVAXIS, INC., ADVAXIS, INC., AYALA PHARMACEUTICALS, INC., Advaxis, Inc., Ayala Pharmaceuticals, Inc., GREAT EXPECTATIONS & ASSOCIATES INC